Guide for paediatric radiotherapy procedures.
Fiche publication
Date publication
décembre 2021
Journal
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique
Auteurs
Membres identifiés du Cancéropôle Est :
Dr BERNIER-CHASTAGNER Valérie
Tous les auteurs :
Laprie A, Bernier V, Padovani L, Martin V, Chargari C, Supiot S, Claude L
Lien Pubmed
Résumé
A third of children with cancer receive radiotherapy as part of their initial treatment, which represents 800 paediatric irradiations per year in France carried out in 15 specialized centres approved on the recommendations of the French national cancer institute in decreasing order of frequency, the types of cancer that require irradiation are: brain tumours, neuroblastomas, Ewing's sarcomas, Hodgkin's lymphomas, soft tissue sarcomas including rhabdomyosarcomas, and nephroblastomas. The treatment guidelines follow the recommendations of the French society for childhood cancers (SFCE) or the French and European prospective protocols. The therapeutic indications, the technical and/and ballistic choices of complex cases are frequently discussed during bimonthly paediatric radiotherapy technical web-conferences. All cancers combined, overall survival being 80%, long-term toxicity logically becomes an important concern, making the preparation of treatments complex. The irradiation methods include all the techniques currently available: 3D conformational irradiation, intensity modulation radiation therapy, irradiation under normal or hypofractionated stereotaxic conditions, brachytherapy and proton therapy. We present the update of the recommendations of the French society for radiation oncology on the indications, the technical methods of realization and the organisation and the specificities of paediatric radiation oncology.
Mots clés
Brain tumour, Cancers de l’enfant, Ewing's sarcoma, Guidelines, Neuroblastoma, Neuroblastome, Paediatric cancer, Protontherapy, Radiation therapy, Radiothérapie, Recommandations, Rotonthérapie, Sarcome d’Ewing, Société française de radiothérapie oncologique, Tumeurs cérébrales
Référence
Cancer Radiother. 2021 Dec 27;: